BACKGROUND AND OBJECTIVES: Oxaliplatin is a chemotherapeutic drug for colorectal adenocarcinoma able to extend the indications for resection of colorectal liver metastases. However, the drug may severely injure hepatic sinusoids, inducing a sinusoidal obstruction syndrome in non-tumoral parenchyma with a risk of decreased regeneration in the remnant liver following partial hepatectomy. METHODS: We then investigated the evolution of hepatic functions and liver regeneration following partial hepatectomy in rats with sinusoidal obstruction syndrome. The sinusoidal obstruction syndrome was induced with a single intragastric administration of monocrotaline (MCT). RESULTS: MCT administration induced obstruction of the hepatic microcirculation and...
AbstractBackgroundOxaliplatin‐based chemotherapy has been linked to the development of sinusoidal ob...
OBJECTIVES: The most frequent presentation of chemotherapy-related toxicity in colorectal liver meta...
Objectives: The most frequent presentation of chemotherapy-related toxicity in colorectal liver meta...
Administering Oxaliplatin prior to resection of colorectal liver metastases often induces a Sinusoid...
Background & AimsSinusoidal obstruction syndrome (SOS) following oxaliplatin based chemotherapy can ...
Background & aimsSinusoidal obstruction syndrome (SOS) following oxaliplatin based chemotherapy can ...
AIMS: Oxaliplatin is an important chemotherapeutic agent, used in the treatment of hepatic colorecta...
Vreuls C P H, Van Den Broek M A, Winstanley A, Koek G H, Wisse E, Dejong C H, Olde Damink S W M, Bos...
BACKGROUND: Sinusoidal obstruction syndrome (SOS) occurs in 50-70% of patients after oxaliplatin tre...
Oxaliplatin-based chemotherapy plays an important role in the treatment of colorectal liver metastas...
PhD ThesisOxaliplatin based chemotherapy has demonstrated remarkable efficacy in down staging color...
Oxaliplatin is an effective chemotherapeutic agent for the treatment of colorectal cancer; however, ...
(1) Background: Sinusoidal obstruction syndrome (SOS) after oxaliplatin-based chemotherapy is associ...
AIMS: Because of its efficacy, oxaliplatin (OX) is increasingly used as a chemotherapeutic agent in ...
Background: In advanced metastatic colorectal adenocarcinoma, the addition of a neo-adjuvant systemi...
AbstractBackgroundOxaliplatin‐based chemotherapy has been linked to the development of sinusoidal ob...
OBJECTIVES: The most frequent presentation of chemotherapy-related toxicity in colorectal liver meta...
Objectives: The most frequent presentation of chemotherapy-related toxicity in colorectal liver meta...
Administering Oxaliplatin prior to resection of colorectal liver metastases often induces a Sinusoid...
Background & AimsSinusoidal obstruction syndrome (SOS) following oxaliplatin based chemotherapy can ...
Background & aimsSinusoidal obstruction syndrome (SOS) following oxaliplatin based chemotherapy can ...
AIMS: Oxaliplatin is an important chemotherapeutic agent, used in the treatment of hepatic colorecta...
Vreuls C P H, Van Den Broek M A, Winstanley A, Koek G H, Wisse E, Dejong C H, Olde Damink S W M, Bos...
BACKGROUND: Sinusoidal obstruction syndrome (SOS) occurs in 50-70% of patients after oxaliplatin tre...
Oxaliplatin-based chemotherapy plays an important role in the treatment of colorectal liver metastas...
PhD ThesisOxaliplatin based chemotherapy has demonstrated remarkable efficacy in down staging color...
Oxaliplatin is an effective chemotherapeutic agent for the treatment of colorectal cancer; however, ...
(1) Background: Sinusoidal obstruction syndrome (SOS) after oxaliplatin-based chemotherapy is associ...
AIMS: Because of its efficacy, oxaliplatin (OX) is increasingly used as a chemotherapeutic agent in ...
Background: In advanced metastatic colorectal adenocarcinoma, the addition of a neo-adjuvant systemi...
AbstractBackgroundOxaliplatin‐based chemotherapy has been linked to the development of sinusoidal ob...
OBJECTIVES: The most frequent presentation of chemotherapy-related toxicity in colorectal liver meta...
Objectives: The most frequent presentation of chemotherapy-related toxicity in colorectal liver meta...